Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
eBook - ePub

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

,
  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

,

About this book

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa.The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS by in PDF and/or ePUB format. We have over one million books available in our catalogue for you to explore.

Information

Edition
0

Table of contents

  1. COVER PAGE
  2. TITLE PAGE
  3. COPYRIGHT PAGE
  4. TABLE OF CONTENTS
  5. ACRONYMS
  6. 1 INTRODUCTION AND OVERVIEW OF THE WORKSHOP
  7. 2 THE CHALLENGES AND OPPORTUNITIES FOR THE BRICS COUNTRIES TO LEAD
  8. 3 CATCHING UP WITH THE MICROBE
  9. 4 DRUG-RESISTANT TB IN CHINA
  10. 5 EXPERIENCES WITH MDR TB IN OTHER COUNTRIES
  11. 6 DRUG-RESISTANT TUBERCULOSIS IN PEDIATRIC POPULATIONS
  12. 7 GLOBAL PERSPECTIVES ON TRANSMISSION AND INFECTION CONTROL
  13. 8 RAPID DIAGNOSTIC TECHNOLOGIES: STATUS AND LIMITATIONS
  14. 9 ADDRESSING DIAGNOSIS AND TREATMENT ACROSS THE SPECTRUM OF DRUG RESISTANCE
  15. 10 DEVELOPING AND STRENGTHENING THE DRUG SUPPLY CHAIN FOR DRUG-RESISTANT TB
  16. 11 EMBRACING A NEW VISION FOR RESEARCH
  17. 12 WHAT WILL BE REQUIRED TO ACHIEVE ZERO DEATHS FROM TB?
  18. 13 CREATING AN EVIDENCE-BASED BLUEPRINT FOR ACTION
  19. REFERENCES
  20. APPENDIXES